Cargando…

Everolimus Related Fulminant Hepatitis in Pancreatic Neuroendocrine Tumor With Liver Metastases: A Case Report and Literature Review

BACKGROUND: Everolimus, an immunosuppressant, is approved for the treatment of advanced renal cell carcinoma, metastatic hormone receptor-positive breast cancer, and pancreatic neuroendocrine tumors (P-NETs) but has been reported to be related to hepatitis B reactivation. Here, we present the first...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Shih-Chun, Tsai, Chun-Yi, Liu, Keng-Hao, Wang, Shang-yu, Hsu, Jun-Te, Yeh, Ta-Sen, Yeh, Chun-Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047461/ https://www.ncbi.nlm.nih.gov/pubmed/33868173 http://dx.doi.org/10.3389/fendo.2021.639967

Ejemplares similares

Selective reoperation after primary resection as a feasible and safe treatment strategy for recurrent pancreatic cancer
por: Chang, Shih-Chun, et al.
Publicado: (2016)

Non‐small cell lung cancer with gastric metastasis and repeated gastrointestinal bleeding: A rare case report and literature review
por: Shih‐Chun, Chang, et al.
Publicado: (2021)

Risk factors of recurrent secondary hyperparathyroidism after adequate primary surgical treatment
por: Kuo, Yu-Chi, et al.
Publicado: (2023)

N3 Subclassification Incorporated into the Final Pathologic Staging of Gastric Cancer: A Modified System Based on Current AJCC Staging
por: Yeh, Chun-Nan, et al.
Publicado: (2015)

Prediction of Gastric Gastrointestinal Stromal Tumors before Operation: A Retrospective Analysis of Gastric Subepithelial Tumors
por: Lin, Yu-Ning, et al.
Publicado: (2022)

Surgical options for submucosal tumors near the esophagogastric junction: does size or location matter?
por: Huang, Yi-Chun, et al.
Publicado: (2020)

Gastroesophageal Reflux Disease Symptoms after Laparoscopic Sleeve Gastrectomy: A Retrospective Study
por: Wu, Wen-Yang, et al.
Publicado: (2022)

Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer
por: Chiang, Kun-Chun, et al.
Publicado: (2012)

Isolated pancreatic metastasis from rectal cancer: a case report and review of literature
por: Lee, Chao-Wei, et al.
Publicado: (2010)

Prognostic Value of the Metastatic Lymph Node Ratio in Patients With Resectable Carcinoma of Ampulla of Vater
por: Hsu, Chih-Ho, et al.
Publicado: (2015)

Metabolism of Proteins and Amino Acids in Critical Illness: From Physiological Alterations to Relevant Clinical Practice
por: Hsu, Chih-Chieh, et al.
Publicado: (2021)

The Severity of Postoperative Pancreatic Fistula Predicts 30-Day Unplanned Hospital Visit and Readmission after Pancreaticoduodenectomy: A Single-Center Retrospective Cohort Study
por: Kou, Hao-Wei, et al.
Publicado: (2022)

Cytoreductive Surgery may be beneficial for highly selected patients with Metastatic Gastrointestinal Stromal Tumors receiving Regorafenib facing Local Progression: A Case Controlled Study
por: Yeh, Chun-Nan, et al.
Publicado: (2021)

Everolimus and mTOR inhibition in pancreatic neuroendocrine tumors
por: Yim, Kein-Leong
Publicado: (2012)

Clinicopathologic features and outcomes following surgery for pancreatic adenosquamous carcinoma
por: Hsu, Jun-Te, et al.
Publicado: (2008)

A real-life treatment cohort of pancreatic neuroendocrine tumors: High-grade increase in metastases confers poor survival
por: Zhang, Wu-Hu, et al.
Publicado: (2022)

Treatment of advanced pancreatic neuroendocrine tumors: potential role of everolimus
por: Cen, Putao, et al.
Publicado: (2012)

Effectiveness and Prognostic Factors of Everolimus in Patients with Pancreatic Neuroendocrine Neoplasms
por: Kurita, Yusuke, et al.
Publicado: (2022)

Diabetes in Patients With Pancreatic Neuroendocrine Neoplasms
por: Zhuge, Xiaoling, et al.
Publicado: (2020)

Aggressive neuroendocrine tumor of the ovary with multiple metastases treated with everolimus: A case report
por: Kaiho-Sakuma, Michiko, et al.
Publicado: (2018)

Assessing the role of everolimus in reducing hepatocellular carcinoma recurrence after living donor liver transplantation for patients within the UCSF criteria: re-inventing the role of mammalian target of rapamycin inhibitors
por: Thorat, Ashok, et al.
Publicado: (2017)

Molecular Signatures and Their Clinical Utility in Pancreatic Neuroendocrine Tumors
por: Chatani, Praveen Dilip, et al.
Publicado: (2021)

Application of mentorship program for another aspect of surgical residency training: The importance of academia in surgical training
por: Chan, Kun-Ming, et al.
Publicado: (2021)

Impact of Pancreatic Resection on Survival in Locally Advanced Resectable Gastric Cancer
por: Chang, Shih-Chun, et al.
Publicado: (2021)

Human Immunocompetent Model of Neuroendocrine Liver Metastases Recapitulates Patient-Specific Tumour Microenvironment
por: Doornebal, Ewald Jan, et al.
Publicado: (2022)

Regorafenib treatment outcome for Taiwanese patients with metastatic gastrointestinal stromal tumors after failure of imatinib and sunitinib: A prospective, non-randomized, single-center study
por: Hu, Chia-Hsiang, et al.
Publicado: (2020)

Hypovascular pancreatic neuroendocrine tumor with hepatic metastases: A case report and literature review
por: Doan, Ngo-Van, et al.
Publicado: (2021)

Neuroendocrine Tumor Metastases to the Breast: A Case Report and Review of the Literature
por: Urrego Díaz, Jose A, et al.
Publicado: (2023)

Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome
por: Wang, Shang-Yu, et al.
Publicado: (2019)

Feasibility and Timing of Cytoreduction Surgery in Advanced (Metastatic or Recurrent) Gastrointestinal Stromal Tumors During the Era of Imatinib
por: Chang, Shih-Chun, et al.
Publicado: (2016)

The impact of preoperative etiology on emergent pancreaticoduodenectomy for non-traumatic patients
por: Tsai, Chun-Yi, et al.
Publicado: (2017)

IGF-I Influences Everolimus Activity in Medullary Thyroid Carcinoma
por: Gentilin, Erica, et al.
Publicado: (2015)

Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy
por: Hu, Yuheng, et al.
Publicado: (2021)

Characteristics of small pancreatic neuroendocrine tumors and risk factors for invasion and metastasis
por: Mei, Wentong, et al.
Publicado: (2023)

Metabolism of pancreatic neuroendocrine tumors: what can omics tell us?
por: Jannin, Arnaud, et al.
Publicado: (2023)

The Role of Primary Tumor Resection in Patients With Pancreatic Neuroendocrine Tumors With Liver Metastases
por: Mou, Yu, et al.
Publicado: (2022)

Therapeutics for fulminant hepatitis caused by enteroviruses in neonates
por: Wang, Li-Chiu, et al.
Publicado: (2022)

Everolimus and sunitinib for advanced pancreatic neuroendocrine tumors: a matching-adjusted indirect comparison
por: Signorovitch, James, et al.
Publicado: (2013)

Prolonged Clinical Benefit of Everolimus Therapy in the Management of High-Grade Pancreatic Neuroendocrine Carcinoma
por: Fonseca, Paula J., et al.
Publicado: (2013)

Prognostic impact of the cumulative dose and dose intensity of everolimus in patients with pancreatic neuroendocrine tumors
por: Berardi, Rossana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8ou4pqljs4iiosv5201v460k96